Today: 22 May 2026
Costco stock price forecast: Wall Street’s $1,000 call meets a holiday-sales test after the bell
7 January 2026
1 min read

Costco stock price forecast: Wall Street’s $1,000 call meets a holiday-sales test after the bell

New York, January 7, 2026, 15:41 EST — Regular session

  • Costco shares slid about 0.6% in afternoon trade as investors waited for December sales due after the close
  • A Mizuho upgrade to “outperform” and a $1,000 target has refocused attention on near-term growth signals
  • Next catalysts include today’s sales release, a Jan. 15 shareholder meeting and a March 5 earnings call

Costco Wholesale Corp shares eased on Wednesday as traders braced for a December sales update due after the bell, a report that could reset near-term views on the stock. The shares were down 0.6% at $884.07 in afternoon trade.

The timing matters. Costco’s monthly sales releases are one of the few hard reads investors get between earnings on holiday demand, traffic and membership momentum — the engine that helps fund profits.

It also lands at an awkward moment for forecasts. The stock is still well below last year’s peak, and investors have been debating whether growth is cooling or just getting harder to measure as stores stay packed and new warehouses open.

Costco last reported quarterly results in December, when it beat Wall Street estimates on revenue and profit. Same-store sales — a gauge of sales at locations open at least a year — rose 6.4% excluding gasoline, and an Omnisend adviser said shoppers were “looking to stretch their dollar further.” Reuters

A bullish note from Mizuho has kept the $1,000 level in the conversation. Analyst David Bellinger upgraded Costco to outperform and raised his price target to $1,000, saying concerns “stem from … too much consumer demand,” MarketWatch reported — a view that frames crowded warehouses as a constraint, not a warning sign. MarketWatch

The tape has been choppy. Costco closed up 1.53% on Tuesday at $889.10 but lagged some big retail peers on the day, with Amazon jumping 3.38% while Walmart and Target also rose, MarketWatch data showed. Costco shares were about 17.5% below their 52-week high of $1,078.24 set on Feb. 13. 

Investors will be reading the sales release for comparable sales and online growth, and for any hint that traffic is shifting between older stores and newer “fill-in” locations. On Costco’s last earnings call, management said it would report December sales for the five weeks ending Sunday, Jan. 4, after market close on Jan. 7. The Motley Fool

After that, the calendar gets busier. Costco’s proxy statement sets a virtual shareholder meeting for Jan. 15 at 2:00 p.m. Pacific, and the company’s investor site lists its fiscal second-quarter earnings call for March 5 at 2:00 p.m. Pacific. 

But the setup cuts both ways. A softer sales print, or signs that membership growth and renewals are cooling, could push investors back toward the bear case — that Costco’s premium valuation needs steady, clean growth to hold. Cost pressures, especially labor, remain a swing factor.

Costco’s investor calendar lists the December sales results for 1:15 p.m. Pacific (4:15 p.m. ET) on Wednesday, shortly after the U.S. market close. 

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
PLTR stock price forecast: Palantir climbs as Truist slaps $223 target on shares
Previous Story

PLTR stock price forecast: Palantir climbs as Truist slaps $223 target on shares

CoreWeave stock price forecast: Wall Street still sees $121 target after Nvidia Rubin news, but shares wobble
Next Story

CoreWeave stock price forecast: Wall Street still sees $121 target after Nvidia Rubin news, but shares wobble

Go toTop